Categories: News

Sibannac, Inc. Announces Revenue Through Sales of Its Kratom Energy Shot with New York City and Las Vegas Distribution

Scottsdale, Arizona–(Newsfile Corp. – September 7, 2023) – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

Sibannac, Inc., through its newly acquired subsidiary brand – Letz Go Energy – the flagship brand of the Company’s Immersive Brand Concepts, is thrilled to announce its exciting debut in the Big Apple and Las Vegas Nevada, partnering with the esteemed distributors, AH80 and Hygeia Distribution. To mark this revenue milestone, Letz Go Energy introduces its revolutionary Kratom Energy Shot, a game-changing product infused with natural ingredients and unique catalyst properties designed and known to elevate mood, provide pain relief, and enhance focus.

These orders are for three SKU’s of our 2oz Kratom Energy Shot, comprising over 30,000 initial units to be distributed between NYC and Las Vegas. The orders are for our Fireball, Strawberry/Banana and Blueberry Blitz Kratom shots and the parties will be closely evaluating sales penetration and adoption in anticipation of near-term subsequent orders. We will be offering products direct to consumer as well at Let’s Go Shot. Our NOHO After Shot – a reengineered hangover remedy – is now for sale online, direct-to-consumer. An initial run of the NOHO shot has resulted in an updated formulation and flavor profile, after evaluation, including customer feedback.

Letz Go Energy’s product line is set to revolutionize the energy supplement industry, offering consumers an accessible and over-the-counter solution to a range of everyday ailments, while also providing the commonly reported added benefits of increased focus and vitality.

Our Kratom shots boast a host of innovative features that set it apart from other products on the market. The Kratom Energy Shot contains natural ingredients carefully selected to provide a holistic approach to energy and wellness. The secret to our Kratom shot’s effectiveness lies in its unique catalyst properties. Crafted by experts and designed to optimize the delivery of key ingredients, these properties ensure both quicker impact and longer-lasting effects.

Our Kratom shots target these three main areas of consumer need:

Mood Elevation
Pain Relief
Enhanced Focus

Sibannac’s Immersive Brand Concepts is known for its commitment to innovation and improving the lives of consumers. This new product line is a testament to their dedication to providing accessible solutions for everyday wellness, according to Immersive’s CEO, Karl Gottschalk.

“We’re excited to introduce Letz Go Energy and our Kratom Energy Shot to the vibrant city of New York through our partnership with AH80,” said Karl Gottschalk , Founder and CEO of Immersive Brand Concepts. “Our mission is to make wellness accessible to everyone, and we believe that our unique blend of natural ingredients and catalyst properties in the Kratom Energy Shot will help people feel their best, every day.”

David Merky, Sibannac Inc.’s CEO, stated, “We’re now in revenue with our Kratom shots and this is just the beginning. Karl is the consummate professional and has designed our Kratom products with key attributes not found in most other competing products. Our shots contain catalysts that result in more absorption and overall increased effectiveness which we believe will take the Kratom market by storm as we roll them out. Utilizing the same approach and similar tech Karl has famously brought to the THC space, we aim to be the market leader in Kratom. With Karl’s innovations and formulations, we’re going to be hard to beat!”

About Immersive Brand Concepts

Immersive Brand Concepts, Inc is a subsidiary of Sibannac Inc. and is an industry innovator in delivering exceptional products for Hangover Prevention, Organic Immune Supplements and Kratom. With a commitment to innovation and customer satisfaction, the company strives to shape the future of these industries through its brands, partnerships, operational excellence, and cutting-edge formulation and manufacturing processes.

About Sibannac

Sibannac, Inc. (OTC Pink: SNNC) is a Nevada corporation founded in 1999 and located in Scottsdale, Arizona. Sibannac currently specializes in creating and selling premium next generation wellness products in the consumer packaging goods space. In addition to mainstream supplements, the Company is producing Kratom and Hemp-derived Delta-8/9 products, and Amanita mushroom edibles for wholesale and retail sales and distribution. Sibannac provides contract manufacturing and white labeling services for independent firms and creates and manages its own brands from the concept phase through to distribution. Sibannac has opened its platform to outside clients to offer its marketing and brand-building assets, through its wholly owned subsidiaries, The Campus Co. and Immersive Brand Concepts.

More from Sibannac – For additional information and product updates, please follow us at The Campus Co. and follow us on Twitter at www.twitter.com/sibannacinc.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Media Contact: IR@theCampusCo.com
Twitter: @SibannacInc

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/179764

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

4 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

5 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

5 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago